Atlanta, GA  October 14, 2009  – The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James) has entered into a contract with Global Vision Technologies (GVT) to create and deliver a new, web-based Photo Dynamic Therapy patient registry solution -- ClinicalPURSUIT--  to help streamline the data collection and outcomes analysis process. 

Photodynamic therapy (PDT) is a treatment that uses drugs, called photosensitizing agents, along with light to kill cancer cells. Depending on the part of the body being treated, the photosensitizing agent is either injected into the bloodstream or put on the skin. Over a certain amount of time the drug is absorbed by the cancer cells. Then light is applied to the area to be treated. The light causes the drug to react with oxygen, which forms a chemical that kills the cancer cells.

Today, expensive market research and time-to-ramp-up delays are two costly issues confronting medical research teams, medical centers and pharmaceutical organizations.  With ClinicalPURSUIT, GVT delivers a powerful, cost-effective patient registry software tool that will help OSUCCC-James work with real-time, accurate information on their patients daily. 

“ClinicalPURSUIT is a HIPAA compliant, tailored patient registry solution and is built on GVT’s Vision Server .NET architecture – which allows for rapid development and customization.  The new PDT registry enables our clients to collect data securely and rapidly from multiple centers in a collaborative effort.  The data can then be compiled, accessed and analyzed giving valuable insight into what’s working and how to further improve the outcomes of patients.” remarked, George Ritacco, Executive Director, Client Services at GVT.

About Global Vision Technologies
GVT is a provider of world-class information management solutions for patient registries (ClinicalPURSUIT), child welfare case management software (FAMCare) and e-learning management solutions (OmniTrackPlus).  GVT delivers highly-secure, custom systems tailored to a client’s needs for improved productivity, workflow and reduced costs.  For more information on ClinicalPURSUIT, please visit www.patientregistrysoftware.com 

About The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute
The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute is one of only 40 Comprehensive Cancer Centers in the United States designated by the National Cancer Institute. Ranked by U.S. News & World Report among the top 20 cancer hospitals in the nation, The James (www.jamesline.com ) is the 180-bed adult patient-care component of the cancer program at The Ohio State University. The OSUCCC-James is one of only five centers in the country approved by the NCI to conduct both Phase I and Phase II clinical trials.